InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: Investintin post# 286246

Tuesday, 03/20/2018 8:37:29 AM

Tuesday, March 20, 2018 8:37:29 AM

Post# of 402518

So you are saying the HAL study has NOTHING to do with the agonist bead?

I guess changing the formulation of the agonist excipients will not change its bioavailability and will not affect the pharmacodynamics and absorption of both drugs at all... good to know.







Bioavailability and pharmacodynamics will be assessed with the pivotal BE study, not a HAL study, and yes, that is a good to know.






Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News